Healthcare & Life Sciences
Oncoethix
Switzerland
acquiredacquired
acquired
Stage
1
Investors
About
Oncoethix was a clinical-stage oncology company focused on developing novel targeted therapies for cancer. It was acquired by Merck & Co. in 2014.
Explore Oncoethix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.